BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Prantera C, Rizzi M. 5-ASA in ulcerative colitis: Improving treatment compliance. World J Gastroenterol 2009; 15(35): 4353-4355 [PMID: 19764084 DOI: 10.3748/wjg.15.4353]
URL: https://www.wjgnet.com/1007-9327/full/v15/i35/4353.htm
Number Citing Articles
Gary R. Lichtenstein, Andrew C. Barrett, Enoch Bortey, Craig Paterson, William P. Forbes. Long-term Safety and Tolerability of Once-daily Mesalamine Granules in the Maintenance of Remission of Ulcerative ColitisInflammatory Bowel Diseases 2014; 20(8): 1399 doi: 10.1097/MIB.0000000000000076
El Bethel Lalthavel Hmar, Sujata Paul, Nayanmoni Boruah, Priyanka Sarkar, Sudarshana Borah, Hemanta Kumar Sharma. Apprehending Ulcerative Colitis Management With Springing Up Therapeutic Approaches: Can Nanotechnology Play a Nascent Role?Current Pathobiology Reports 2021; 9(1): 9 doi: 10.1007/s40139-020-00218-6
Radan Keil, Martin Wasserbauer, Zdena Zádorová, Vladimír Kojecký, Štěpán Hlava, Jan Št’ovíček, Jakub Chudý, Markéta Roznětinská, Jiří Drábek, Nikola Kubišová, Jindra Lochmannová. Adherence, risk factors of non-adherence and patient’s preferred treatment strategy of mesalazine in ulcerative colitis: multicentric observational studyScandinavian Journal of Gastroenterology 2018; 53(4): 459 doi: 10.1080/00365521.2018.1451915
Chien Nguyen, J. Mark Christensen, James W. Ayres. Novel mesalamine-loaded beads in tablets for delayed release of drug to the colonPharmaceutical Development and Technology 2012; 17(1): 73 doi: 10.3109/10837450.2010.516436
Jinyi Zhai, Julia Mantaj, Driton Vllasaliu. Ascorbyl Palmitate Hydrogel for Local, Intestinal Delivery of MacromoleculesPharmaceutics 2018; 10(4): 188 doi: 10.3390/pharmaceutics10040188
S. P. L. Travis, P. D. R. Higgins, T. Orchard, C. J. Van Der Woude, R. Panaccione, A. Bitton, C. O’Morain, J. Panés, A. Sturm, W. Reinisch, M. A. Kamm, G. D’Haens. Review article: defining remission in ulcerative colitisAlimentary Pharmacology & Therapeutics 2011; 34(2): 113 doi: 10.1111/j.1365-2036.2011.04701.x
P. Frei, G. Rogler. Topische Therapie bei chronisch-entzündlichen Darmerkrankungencoloproctology 2014; 36(5): 353 doi: 10.1007/s00053-014-0468-3
Michael Stephens, Michelle Gonzalez. Pediatric Inflammatory Bowel Disease2017; : 317 doi: 10.1007/978-3-319-49215-5_25
Tereza Bautzová, Miloslava Rabišková, Alf Lamprecht. Multiparticulate systems containing 5-aminosalicylic acid for the treatment of inflammatory bowel diseaseDrug Development and Industrial Pharmacy 2011; 37(9): 1100 doi: 10.3109/03639045.2011.560156
Michael Stephens, Alisha M. Mavis. Pediatric Inflammatory Bowel Disease2013; : 281 doi: 10.1007/978-1-4614-5061-0_26
Yun-Chu Chen, Sheryhan F. Gad, Dhawal Chobisa, Yongzhe Li, Yoon Yeo. Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunitiesJournal of Controlled Release 2021; 330: 438 doi: 10.1016/j.jconrel.2020.12.025
Sidhartha R. Sinha, Linh P. Nguyen, Mohammed Inayathullah, Andrey Malkovskiy, Frezghi Habte, Jayakumar Rajadas, Aida Habtezion. A Thermo-Sensitive Delivery Platform for Topical Administration of Inflammatory Bowel Disease TherapiesGastroenterology 2015; 149(1): 52 doi: 10.1053/j.gastro.2015.04.002
Christopher S.J. Probert, Axel U. Dignass, Stefan Lindgren, Marco Oudkerk Pool, Philippe Marteau. Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: Rapid symptom resolution and improvements in quality of lifeJournal of Crohn's and Colitis 2014; 8(3): 200 doi: 10.1016/j.crohns.2013.08.007
Dae-Seung Kim, Sung-Hee Kim, Ji-Ye Kee, Yo-Han Han, JinBong Park, Jeong-Geon Mun, Moon-Jung Joo, Yong-Deok Jeon, Su-Jin Kim, Sang-Hyun Park, Sung-Joo Park, Jae-Young Um, Seung-Heon Hong. Eclipta prostrataImproves DSS-Induced Colitis through Regulation of Inflammatory Response in Intestinal Epithelial CellsThe American Journal of Chinese Medicine 2017; 45(05): 1047 doi: 10.1142/S0192415X17500562
Bryan L Love, April D Miller. Extended-Release Mesalamine Granules for Ulcerative ColitisAnnals of Pharmacotherapy 2012; 46(11): 1529 doi: 10.1345/aph.1R171
P. Frei, G. Rogler. Topische Therapie bei chronisch-entzündlichen DarmerkrankungenDer Gastroenterologe 2013; 8(3): 197 doi: 10.1007/s11377-012-0724-4
F. Seibold, N. Fournier, C. Beglinger, C. Mottet, V. Pittet, G. Rogler. Topical therapy is underused in patients with ulcerative colitisJournal of Crohn's and Colitis 2014; 8(1): 56 doi: 10.1016/j.crohns.2013.03.005
Yan-cheng Dai, Zhi-peng Tang, Zhen-nan Wang, Ya-li Zhang, Xin-ying He. Influence of Shenqing Recipe on Morphology and Quantity of Colonic Interstitial Cells of Cajal in Trinitrobenzene Sulfonic Acid Induced Rat ColitisChinese Medical Sciences Journal 2011; 26(1): 43 doi: 10.1016/S1001-9294(11)60018-7
H. Ueyama, KI. Fu, K. Ogura, S. Murata, A. Miyazaki. Successful treatment for Cronkhite-Canada syndrome with endoscopic mucosal resection and salazosulfapyridineTechniques in Coloproctology 2014; 18(5): 503 doi: 10.1007/s10151-012-0863-0
Salam F. Zakko, Glenn L. Gordon, Uma Murthy, Shahriar Sedghi, Ronald Pruitt, Andrew C. Barrett, Enoch Bortey, Craig Paterson, William P. Forbes, Gary R. Lichtenstein. Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factorsPostgraduate Medicine 2016; 128(3): 273 doi: 10.1080/00325481.2016.1152876
Andreea Aprodu, Julia Mantaj, Bahijja Raimi-Abraham, Driton Vllasaliu. Evaluation of a Methylcellulose and Hyaluronic Acid Hydrogel as a Vehicle for Rectal Delivery of BiologicsPharmaceutics 2019; 11(3): 127 doi: 10.3390/pharmaceutics11030127
Michelle Gonzalez, Michael Stephens. Pediatric Inflammatory Bowel Disease2023; : 339 doi: 10.1007/978-3-031-14744-9_25